Ciclopirox 0,77% VCP itchy skin cream treatment – Antifungal Treatment – Free shipping

1. About Ciclopirox 0,77% VCP itchy skin cream treatment

Ciclopirox 0,77% VCP itchy skin cream treatment – Antifungal Treatment is a topical antifungal cream formulated to treat various skin fungal infections. Each gram of the cream contains 7.7 mg of the active ingredient ciclopirox. The product is manufactured by VCP Pharmaceutical Joint Stock Company in Vietnam and is available in a 15g tube.

2. Indications

This cream is indicated for the treatment of the following fungal skin infections:

• Tinea Pedis (Athlete’s Foot): Caused by fungi such as Trichophyton rubrum and Trichophyton mentagrophytes.
• Tinea Cruris (Jock Itch): Infections in the groin area due to fungi like Epidermophyton floccosum.
• Tinea Corporis (Ringworm): Fungal infections on the body caused by Microsporum canis.
• Candidiasis: Skin infections caused by Candida albicans.
• Pityriasis Versicolor (Tinea Versicolor): Caused by Malassezia furfur.

These conditions are characterized by symptoms such as itching, redness, and scaling of the skin.

3. Pharmacology

• Pharmacodynamics: Ciclopirox is a hydroxypyridone antifungal agent that works by chelating polyvalent cations (e.g., Fe³⁺ or Al³⁺), inhibiting metal-dependent enzymes responsible for the degradation of peroxides within fungal cells, leading to cell death. It exhibits a broad spectrum of antifungal activity against dermatophytes, yeasts, and molds.
• Pharmacokinetics: When applied topically, ciclopirox is minimally absorbed into the systemic circulation (less than 2% through intact skin). It rapidly distributes into the stratum corneum, hair follicles, sebaceous glands, and dermis. The absorbed portion is metabolized and excreted primarily through urine.

  

4. Dosage and Administration

• Adults: Apply a thin layer of the cream to the affected area twice daily, in the morning and evening. Cleanse and dry the affected area thoroughly before application. Wash hands before and after applying the cream. Avoid covering the treated area with occlusive dressings unless directed by a healthcare provider. If there is no improvement after four weeks of treatment, re-evaluation of the diagnosis is recommended.
• Pediatric Use: Safety and efficacy in children under 10 years of age have not been established. For children over 10 years, the dosing is similar to adults.

5. Contraindications

Do not use this cream in individuals with known hypersensitivity to ciclopirox or any other components of the formulation.

6. Warnings and Precautions

• External Use Only: The cream is intended for topical use only. Avoid contact with eyes, mucous membranes, and do not ingest.
• Allergic Reactions: If signs of hypersensitivity or irritation occur, discontinue use and consult a healthcare professional.
• Diabetic Patients: Use with caution in insulin-dependent diabetics or those with diabetic neuropathy.
• Pregnancy and Lactation: Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Caution is advised when administered to nursing mothers, although systemic absorption is minimal.

7. Adverse Reactions

Common side effects include mild, transient burning sensations, itching, or redness at the application site. Rarely, allergic reactions such as severe itching, blistering, swelling, or oozing may occur. If severe reactions develop, discontinue use and seek medical attention.

8. Storage

Store the cream at temperatures below 30°C (86°F), away from direct sunlight and moisture. Keep out of reach of children.

9. Additional Information

For more detailed information, including potential drug interactions and comprehensive pharmacological data, consult the product’s prescribing information or contact a healthcare professional.

Note: This summary is intended for informational purposes only and should not replace professional medical advice. Always consult with a healthcare provider for treatment guidance.